Regulation & law · 08/10/1996Updated: 10/18/2026 · 1 min read
Medtronic, Inc. Receives FDA Approval for CapSureFix Pacing Lead, Model 4068
Summary
The US Food and Drug Administration (FDA) has approved Medtronic, Inc.'s application for premarket approval of the CapSureFix Pacing Lead, Model 4068, under the Federal Food, Drug, and Cosmetic Act, following notification by the FDA's Center for Devices and Radiological Health on March 29, 1996.
Original source language: Federal Register — All DocumentsOpen original release →